Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects

PURPOSE: Glimepiride, an FDA-approved oral hypoglycemic drug, is a long-acting sulfonylurea (SU), used for treating type 2 diabetes. The study aimed to evaluate the bioequivalence and safety profiles of two different formulations of glimepiride 1 mg from two different manufactures in healthy Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Gehang, Yan, Keyu, Xu, Youwei, Chen, Shilin, Zheng, Zhonghui, Qiu, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351633/
https://www.ncbi.nlm.nih.gov/pubmed/32753845
http://dx.doi.org/10.2147/DDDT.S249355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351633/
https://www.ncbi.nlm.nih.gov/pubmed/32753845
http://dx.doi.org/10.2147/DDDT.S249355

Ejemplares similares